SABCS and ASH findings: palbociclib improves PFS in HR+, HER2+ breast cancer, cilta-cel achieves 100% CR in smoldering MM, and selinexor with ruxolitinib aids myelofibrosis.
Sanjay K. Juneja, MD, discusses how artificial intelligence has evolved in 2024 to help improve early detection of cancer. Sanjay K. Juneja, MD, hematologist & medical oncologist at Mary Bird Perkins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback